Gradalis CL-PTL-135
Trial Overview
Official Title
Blood and Tissue Procurement Protocol for Product Development and Research
Study Purpose
To collect cancerous tissue/fluid and blood samples to store and use for research purposes.
Diagnosis
Patients who will have or already have had a procedure to remove the cancerous tissue from their body.Eligibility
Ovarian cancer patients who will be undergoing a biopsy or surgery (front-line and recurrent patients both accepted, all stages accepted)
Patients must sign an approved informed consent and authorization permitting release of personal health information.
Intervention
Observational – Blood and Tissue collection only
Key Participation Requirements
Trial Location(s)
Gender
Female
Age
19 years and older
Enrollment Status
Recruiting
Phase
Not Applicable
Methodist Health System Trial Code
CL-PTL-135